Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Maxwell

Showing results (341-350 of 345) with videos related to

Pageof 35
Sort By:
You have reached the last page of results.This site can display upto 345 results.
ACS Chemical Biology|December 12, 2023
Discovery of High Affinity Cyclic Peptide Ligands for Human ACE2 with SARS-CoV-2 Entry Inhibitory ActivityMax J Bedding, Charlotte Franck, Jason Johansen-Leete, et al.
Nature Communications|November 15, 2022
Mucosal TLR2-activating protein-based vaccination induces potent pulmonary immunity and protection against SARS-CoV-2 in miceAnneliese S Ashhurst, Matt D Johansen, Joshua W C Maxwell, et al.
Nature Communications|January 29, 2026
ClpC1-targeting peptide natural products differentially dysregulate the proteome of Mycobacterium tuberculosisIsabel K Barter, Max J Bedding, Julia Leodolter, et al.
Drug Discovery Today|September 21, 2013
A practical drug discovery project at the undergraduate levelM Jonathan Fray, Simon J F Macdonald, Ian R Baldwin, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Identification of a Novel and Selective Series of Itk Inhibitors via a Template-Hopping StrategyCatherine M Alder, Martin Ambler, Amanda J Campbell, et al.
Pageof 35

Showing results (341-350 of 345) with videos related to

Sort By:
Pageof 35
You have reached the last page of results.This site can display upto 345 results.
ACS Chemical Biology|December 12, 2023
Discovery of High Affinity Cyclic Peptide Ligands for Human ACE2 with SARS-CoV-2 Entry Inhibitory ActivityMax J Bedding, Charlotte Franck, Jason Johansen-Leete, et al.
Nature Communications|November 15, 2022
Mucosal TLR2-activating protein-based vaccination induces potent pulmonary immunity and protection against SARS-CoV-2 in miceAnneliese S Ashhurst, Matt D Johansen, Joshua W C Maxwell, et al.
Nature Communications|January 29, 2026
ClpC1-targeting peptide natural products differentially dysregulate the proteome of Mycobacterium tuberculosisIsabel K Barter, Max J Bedding, Julia Leodolter, et al.
Drug Discovery Today|September 21, 2013
A practical drug discovery project at the undergraduate levelM Jonathan Fray, Simon J F Macdonald, Ian R Baldwin, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Identification of a Novel and Selective Series of Itk Inhibitors via a Template-Hopping StrategyCatherine M Alder, Martin Ambler, Amanda J Campbell, et al.
Pageof 35